Table 5 Regression analyses between ΔTSH and change in listed cardiovascular risk markers as dependent variables over an average follow-up time of 1.7 ± 0.8 years in children and adolescents with obesity (n = 100).
Model 1 | Model 2 | Model 3 | Model 4 | |||||
|---|---|---|---|---|---|---|---|---|
B | p | B | p | B | p | B | p | |
Δ BMI-SDS | 0.05 | 0.12 | 0.05 | 0.11 | 0.05a | 0.11a | 0.04a | 0.19a |
Δ total-cholesterol (mmol/L) | 0.11 | 0.02 | 0.11 | 0.02 | 0.11 | 0.02 | 0.10 | 0.03 |
Δ LDL (mmol/L) | 0.10 | 0.02 | 0.10 | 0.02 | 0.09 | 0.02 | 0.08 | 0.04 |
Δ HDL (mmol/L) | 0.00 | 0.75 | 0.00 | 0.85 | 0.01 | 0.70 | 0.01 | 0.69 |
Δ LDL/HDL | 0.15 | <0.01 | 0.15 | <0.01 | 0.13 | <0.01 | 0.12 | <0.01 |
Δ Triglycerides (mmol/L) | 0.13 | <0.01 | 0.13 | <0.01 | 0.12 | <0.01 | 0.12 | <0.01 |
Δ Fasting glucose (mmol/L) | −0.02 | 0.53 | −0.02 | 0.59 | −0.02 | 0.55 | −0.01 | 0.72 |
Δ 2 h OGTT glucose (mmol/L)b | 0.19 | 0.31 | 0.18 | 0.33 | 0.15 | 0.42 | 0.16 | 0.41 |
Δ HbA1c (mmol/L) | 0.34 | 0.17 | 0.31 | 0.21 | 0.23 | 0.36 | 0.29 | 0.24 |
Δ HOMA-IRc | −0.84 | 0.19 | −0.90 | 0.16 | −1.1 | 0.09 | −1.0 | 0.11 |